Two Sigma Investments’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-519,971
| Closed | -$20.6M | – | 3357 |
|
2024
Q1 | $20.6M | Buy |
519,971
+141,558
| +37% | +$5.61M | 0.05% | 407 |
|
2023
Q4 | $7.21M | Buy |
378,413
+187,824
| +99% | +$3.58M | 0.02% | 764 |
|
2023
Q3 | $2.18M | Buy |
190,589
+132,561
| +228% | +$1.52M | 0.01% | 1259 |
|
2023
Q2 | $597K | Buy |
+58,028
| New | +$597K | ﹤0.01% | 2177 |
|
2022
Q4 | – | Sell |
-21,924
| Closed | -$158K | – | 3085 |
|
2022
Q3 | $158K | Buy |
21,924
+1,894
| +9% | +$13.7K | ﹤0.01% | 2108 |
|
2022
Q2 | $170K | Sell |
20,030
-27,678
| -58% | -$235K | ﹤0.01% | 2124 |
|
2022
Q1 | $428K | Sell |
47,708
-31,974
| -40% | -$287K | ﹤0.01% | 2054 |
|
2021
Q4 | $1.1M | Buy |
79,682
+40,464
| +103% | +$561K | ﹤0.01% | 1613 |
|
2021
Q3 | $418K | Buy |
39,218
+22,304
| +132% | +$238K | ﹤0.01% | 2073 |
|
2021
Q2 | $152K | Sell |
16,914
-90,467
| -84% | -$813K | ﹤0.01% | 2269 |
|
2021
Q1 | $1.14M | Sell |
107,381
-41,062
| -28% | -$435K | ﹤0.01% | 1536 |
|
2020
Q4 | $1.87M | Buy |
148,443
+67,078
| +82% | +$845K | 0.01% | 1094 |
|
2020
Q3 | $715K | Buy |
81,365
+3,066
| +4% | +$26.9K | ﹤0.01% | 1288 |
|
2020
Q2 | $760K | Buy |
+78,299
| New | +$760K | ﹤0.01% | 1256 |
|